Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.
Saved in:
| Title: | Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia. |
|---|---|
| Authors: | Beck-Nielsen SS; Centre for Rare Diseases, Aarhus University Hospital, DK-8200 Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, DK-8200 Aarhus, Denmark., Ariceta G; University Hospital Vall d'Hebron, Autonomous University of Barcelona, 08035 Barcelona, Spain., Boot AM; University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands., Brandi ML; FirmoLab, FIRMO Foundation, 50129 Florence, Italy., Briot K; AP-HP, Cochin Hospital, 75014 Paris, France., de Lucas Collantes C; Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, 28009 Madrid, Spain., Emma F; Division of Nephrology, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy., Giannini S; Department of Medicine, University of Padova, 35128 Padova, Italy., Haffner D; Department of Paediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, 30625 Hannover, Germany., Keen R; Metabolic Bone Disease Unit, Royal National Orthopaedic Hospital, Stanmore HA7 4LP, United Kingdom., Levtchenko E; Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Centre, 1105 AZ Amsterdam, The Netherlands., Nilsson O; Karolinska Institutet and University Hospital, ERN BOND, and ENDO ERN, SE-17176 Stockholm, Sweden., Mäkitie O; Children's Hospital, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland., Mughal MZ; Pediatric Endocrinology, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates., Padidela R; Manchester University NHS Foundation Trust Hospital and Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PT, United Kingdom., Tripto-Shkolnik L; Gray Faculty of Medical & Health Sciences, Tel Aviv Center, 6997801 Tel HaShomer, Israel.; Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, 52621 Tel HaShomer, Israel., Zillikens MC; Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., Benchekroun EM; Pharmacovigilance, Kyowa Kirin International Plc, 92976 Paris, France., Eltahan E; Medical Affairs, Kyowa Kirin International Plc, Dubai, United Arab Emirates., Joos-Vandewalle P; Medical Affairs, Kyowa Kirin Co. Ltd., 28046 Madrid, Spain., Melogno-Klinkas M; Medical Affairs, Kyowa Kirin International Plc, 28046 Madrid, Spain., Schnabel D; Pediatric Endocrinology, Center for Chronically Sick Children, Charité Universitätsmedizin, 13353 Berlin, Germany. |
| Source: | European journal of endocrinology [Eur J Endocrinol] 2026 Jul 01; Vol. 195 (1), pp. 10-21. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
